140 related articles for article (PubMed ID: 35504127)
1. Mitophagy: A therapeutic target for oral squamous cell carcinoma.
Balachander K; Paramasivam A
Oral Oncol; 2022 Jun; 129():105881. PubMed ID: 35504127
[No Abstract] [Full Text] [Related]
2. Chronotherapeutics in the management of oral squamous cell carcinoma - A futuristic novel treatment strategy.
Poornachitra P; Muthukrishnan A; Devaraj E
Indian J Cancer; 2023 Oct; 60(4):595-596. PubMed ID: 38185867
[No Abstract] [Full Text] [Related]
3. Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma.
Li CX; Gong ZC; Tan XR
Cancer Immunol Immunother; 2023 Sep; 72(9):3133-3134. PubMed ID: 37149552
[No Abstract] [Full Text] [Related]
4. Marine bioactive compounds as potential therapeutic inhibitor for oral squamous cell carcinoma (OSCC).
Sivaperumal P; Sekaran S; Kamala K; Ganapathy D
Oral Oncol; 2022 Aug; 131():105971. PubMed ID: 35716647
[No Abstract] [Full Text] [Related]
5. MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma.
Selvakumar SC; K Auxzilia P; Dinesh Y; Senthilmurugan M; Sekar D
Oral Oncol; 2022 Jul; 130():105925. PubMed ID: 35606273
[No Abstract] [Full Text] [Related]
6. Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?
Muggia F
Oncologist; 2013; 18(3):245-7. PubMed ID: 23485623
[TBL] [Abstract][Full Text] [Related]
7. Engineered Dex: A promising therapeutic strategy for oral squamous cell carcinoma.
Vijayashree Priyadharsini J; Abilasha R; Anitha P; Paramasivam A
J Stomatol Oral Maxillofac Surg; 2023 Feb; 124(1):101277. PubMed ID: 36058533
[No Abstract] [Full Text] [Related]
8. Engineered exoASO-STAT6: a potent monotherapy for oral squamous cell carcinoma.
Jayaseelan VP; Paramasivam A
Future Oncol; 2022 Aug; 18(25):2767-2769. PubMed ID: 35766123
[No Abstract] [Full Text] [Related]
9. Paraoxonase-2 expression in oral squamous cell carcinoma.
Campagna R; Pozzi V; Salvucci A; Togni L; Mascitti M; Sartini D; Salvolini E; Santarelli A; Lo Muzio L; Emanuelli M
Hum Cell; 2023 May; 36(3):1211-1213. PubMed ID: 36774414
[No Abstract] [Full Text] [Related]
10. Engineered therapeutic bacteria for the treatment of oral squamous cell carcinoma.
Jayaseelan VP; A S SG; Arumugam P
Oral Oncol; 2022 Jul; 130():105874. PubMed ID: 35533508
[No Abstract] [Full Text] [Related]
11. Conspectus on nanodiagnostics as an incipient platform for detection of oral potentially malignant disorders and oral squamous cell carcinoma.
Shanmugam DK; Anitha SC; Najimudeen RA; Saravanan M; Arockiaraj J; Belete MA
Int J Surg; 2023 Mar; 109(3):542-544. PubMed ID: 36906784
[No Abstract] [Full Text] [Related]
12. Early Discovery, Early Recovery: The principle behind successful oral squamous cell carcinoma treatment!
Misra SR; Das R
Oral Oncol; 2023 Oct; 145():106511. PubMed ID: 37478573
[No Abstract] [Full Text] [Related]
13. Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma.
Yang X; Zhou T; Ji T; Jia H; Liu W
Oral Oncol; 2022 Jul; 130():105901. PubMed ID: 35533509
[No Abstract] [Full Text] [Related]
14. The implications of nanodiagnostics and artificial intelligence for detecting oral potentially malignant disorders and oral squamous cell carcinoma.
Liu W; Wang Y; Yang X; Shen X; Shi L
Int J Surg; 2023 Oct; 109(10):3248-3250. PubMed ID: 37352524
[No Abstract] [Full Text] [Related]
15. RET protein is overexpressed in oral squamous cell carcinoma.
Koole K; Peeters T; van Hengel OR; Brinkhuis A; van Es RJ; Willems SM
Histopathology; 2016 Dec; 69(6):1085-1087. PubMed ID: 27344057
[No Abstract] [Full Text] [Related]
16. Telomerase reverse transcriptase mutation: A risk predictor and drug target for oral squamous cell carcinoma and its precursors.
Yuwanati M; Sarode SC; Sarode GS; Gadbail A; Gondivkar S
Oral Oncol; 2022 Nov; 134():106120. PubMed ID: 36096049
[No Abstract] [Full Text] [Related]
17. Oral squamous cell carcinoma in the young patient: an emerging unique cohort of patients.
Kolokythas A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jun; 133(6):617. PubMed ID: 35431174
[No Abstract] [Full Text] [Related]
18. Can koilocytes without dysplasia in OPMDs be an early indicator and prognostic factor for oral squamous cell carcinoma?
Ramdoss R; Yuwanati M; Viola E A; Ramani P; Murugan MS
Oral Oncol; 2022 Jan; 124():105672. PubMed ID: 34920376
[No Abstract] [Full Text] [Related]
19. Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma - "Need for incorporation of sub classification of pT4b lesions".
Amith K P ; V Lal R; Lakshmi Pandey R; Thakur S
Oral Oncol; 2022 Sep; 132():106014. PubMed ID: 35835054
[No Abstract] [Full Text] [Related]
20. [Imaging diagnostic methods for identification of sentinel lymph nodes in patients with early squamous cell carcinoma of the oral cavity mucosa: a literature review].
Gvetadze SR; Lv M; Ilkaev KD; Xiong P; Li J; Yang X; Sun J
Stomatologiia (Mosk); 2017; 96(5):69-73. PubMed ID: 29072651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
